[1]
2018. In-vitro characterisation of a novel antimicrobial agent, TNP-2092, against Helicobacter pylori clinical isolates. Swiss Medical Weekly. 148, 2930 (Jul. 2018), w14630. DOI:https://doi.org/10.4414/smw.2018.14630.